论文部分内容阅读
探讨甲亢采用131I治疗至甲减的危险因素。方法:本研究选择我院2009年1月至2011年1月收治的甲亢患者80例,采取131I治疗,对临床资料进行回顾性分析。结果:X3、X4Logistic回归方程变量与甲亢131I治疗早发甲减相关。其加回归方程具体为:LogitP=1.929+1.650X3-1.79X4,X2=6.770,P<0.05。回归方程差异有统计学意义。本组80例患者中,logistic回归判别未发生甲减的患者70例,准确率92.1%,4例发生甲减,准确率52.6%。结论:临床甲亢在采取131I治疗后可能受多种因素导致早发甲减发生,在患者治疗前需依据其甲状腺的质量对剂量进行调整,可在一定程度上降低早发甲减的发生率,提高患者生存质量。
To explore the use of 131I treatment of hyperthyroidism to hypothyroidism risk factors. Methods: 80 patients with hyperthyroidism admitted to our hospital from January 2009 to January 2011 were enrolled. 131I treatment was performed and the clinical data were retrospectively analyzed. Results: The variables of X3 and X4 Logistic regression equation were correlated with early hypothyroidism with 131I treatment of hyperthyroidism. The regression equation is: LogitP = 1.929 + 1.650X3-1.79X4, X2 = 6.770, P <0.05. The regression equation was statistically significant. The group of 80 patients, logistic regression to identify 70 patients without hypothyroidism, the accuracy rate of 92.1%, 4 cases of hypothyroidism, the accuracy rate of 52.6%. Conclusion: After taking 131I treatment, clinical hypothyroidism may be caused by many factors leading to early hypothyroidism. Before treatment, dosage should be adjusted according to the quality of thyroid, which can reduce the incidence of early hypothyroidism to a certain extent, Improve patient quality of life.